Literature DB >> 16908119

Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea.

David Raveh1, Bella Rabinowitz, Gabriel S Breuer, Bernard Rudensky, Amos M Yinnon.   

Abstract

Data were retrieved from the records of all patients from whom stool was sent for Clostridium difficile toxin testing during the year 2001. Toxin-positive and -negative patients were compared by bivariate analysis and regression models. Eight hundred samples from 610 patients were sent for C. difficile toxin testing. Charts of 535 patients (88%) were available for analysis. Of those, 17% had a positive toxin test whilst 83% had a negative toxin test. There was no difference in the number of daily bowel movements between the two groups. Toxin-positive patients were older (P<0.0001), more often came from nursing homes (P<0.05), had higher leukocyte counts (P<0.001), higher blood urea nitrogen (P<0.01), lower serum albumin (P<0.01) and more often received diuretics (P<0.01) and clindamycin (P<0.05). Logistic regression analysis showed that previous antibiotic-associated diarrhoea was the most significant risk factor for toxin-positive diarrhoea (P<0.001), followed by clindamycin treatment (P<0.005), diuretics (P<0.005) and older age (P<0.05). Another logistic model showed the contribution of macrolides (P<0.05) to the development of hospital-acquired diarrhoea.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908119     DOI: 10.1016/j.ijantimicag.2006.04.013

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  6 in total

1.  Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.

Authors:  I Vesteinsdottir; S Gudlaugsdottir; R Einarsdottir; E Kalaitzakis; O Sigurdardottir; E S Bjornsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-23       Impact factor: 3.267

Review 2.  Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

Authors:  Laura Armengol Álvarez; Greet Van de Sijpe; Stefanie Desmet; Willem-Jan Metsemakers; Isabel Spriet; Karel Allegaert; Jef Rozenski
Journal:  Antibiotics (Basel)       Date:  2022-05-21

3.  Can we improve the therapy of Clostridium difficile infection in elderly patients?

Authors:  Katarina Bielakova; Emmanuela Fernandova; Hana Matejovska-Kubesova; Pavel Weber; Dana Prudius; Josef Bednar
Journal:  Wien Klin Wochenschr       Date:  2016-08-08       Impact factor: 1.704

4.  Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.

Authors:  Preeta K Kutty; Christopher W Woods; Arlene C Sena; Stephen R Benoit; Susanna Naggie; Joyce Frederick; Sharon Evans; Jeffery Engel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

5.  Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection.

Authors:  Vanessa Lang; Katrin Gunka; Jan Rudolf Ortlepp; Ortrud Zimmermann; Uwe Groß
Journal:  Front Microbiol       Date:  2022-03-11       Impact factor: 5.640

6.  Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients.

Authors:  Stojanović Predrag
Journal:  Braz J Microbiol       Date:  2016-07-25       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.